MedTrace Logo

MyoStrain CMR Testing of Ischemia With Low Levels of Stress

NCT03543241 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2018-12-19

No results posted yet for this study

Summary

This prospective, observational study evaluates the accuracy of stress testing with the MyoStrain SENC CMR Imaging System to detect myocardial ischemia and viability in patients with suspected coronary artery disease using low levels of stress.

Conditions

Interventions

DIAGNOSTIC_TEST

MyoStrain

Prior to cardiac catheterization, patients will be stress testing with low dose Dobutamine to evaluate wall motion, segmental, and global myocardial strain at rest and under stress to determine the accuracy of detecting ischemia and viability of myocardial tissue.

Sponsors & Collaborators

  • Myocardial Solutions

    lead INDUSTRY

Principal Investigators

  • Frances Wood, MD · WakeMed Health and Hospitals

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-08
Primary Completion
2018-09-12
Completion
2018-10-18
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03543241 on ClinicalTrials.gov